The FDA recently announced that the national shortage of semaglutide and tirzepatide is over and has notified compounding pharmacies that they must stop manufacturing these medications by May 2025
Cai W, Zhang R, Yao Y, Wu Q, Zhang J
Clinical studies show modest reductions in triglycerides and LDL cholesterol in certain populations, but outcomes depend on baseline lipid status, medication dosage, and metabolic health markers
The wholesalers in these countries can purchase these brand name products and sell them to other countries such as the UK
Is Semaglutide Effective for Weight Loss
However, it's always advisable to read and consult with your doctor